1. Home
  2. GKOS vs LNC Comparison

GKOS vs LNC Comparison

Compare GKOS & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • LNC
  • Stock Information
  • Founded
  • GKOS 1998
  • LNC 1905
  • Country
  • GKOS United States
  • LNC United States
  • Employees
  • GKOS N/A
  • LNC 9783
  • Industry
  • GKOS Medical/Dental Instruments
  • LNC Life Insurance
  • Sector
  • GKOS Health Care
  • LNC Finance
  • Exchange
  • GKOS Nasdaq
  • LNC Nasdaq
  • Market Cap
  • GKOS 5.5B
  • LNC 5.5B
  • IPO Year
  • GKOS 2015
  • LNC N/A
  • Fundamental
  • Price
  • GKOS $100.14
  • LNC $33.01
  • Analyst Decision
  • GKOS Strong Buy
  • LNC Hold
  • Analyst Count
  • GKOS 13
  • LNC 11
  • Target Price
  • GKOS $135.15
  • LNC $36.82
  • AVG Volume (30 Days)
  • GKOS 909.8K
  • LNC 1.4M
  • Earning Date
  • GKOS 07-30-2025
  • LNC 07-31-2025
  • Dividend Yield
  • GKOS N/A
  • LNC 5.45%
  • EPS Growth
  • GKOS N/A
  • LNC N/A
  • EPS
  • GKOS N/A
  • LNC 7.17
  • Revenue
  • GKOS $404,523,000.00
  • LNC $18,544,000,000.00
  • Revenue This Year
  • GKOS $27.88
  • LNC $5.36
  • Revenue Next Year
  • GKOS $27.60
  • LNC $1.67
  • P/E Ratio
  • GKOS N/A
  • LNC $4.61
  • Revenue Growth
  • GKOS 23.92
  • LNC 54.56
  • 52 Week Low
  • GKOS $77.10
  • LNC $27.58
  • 52 Week High
  • GKOS $163.71
  • LNC $39.85
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 58.49
  • LNC 49.09
  • Support Level
  • GKOS $97.54
  • LNC $32.61
  • Resistance Level
  • GKOS $102.82
  • LNC $33.56
  • Average True Range (ATR)
  • GKOS 3.51
  • LNC 0.74
  • MACD
  • GKOS 0.67
  • LNC -0.02
  • Stochastic Oscillator
  • GKOS 77.52
  • LNC 46.32

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

Share on Social Networks: